Target Name: ZC3H7B
NCBI ID: G23264
Review Report on ZC3H7B Target / Biomarker Content of Review Report on ZC3H7B Target / Biomarker
ZC3H7B
Other Name(s): Ubiquitous tetratricopeptide containing protein RoXaN | Rotavirus 'X'-associated non-structural protein | Z3H7B_HUMAN | zinc finger CCCH-type containing 7B | Rotavirus X protein associated with NSP3 |

ZC3H7B: A Ubiquitous Tetratricopeptide Containing Protein RoXaN as A Drug Target Or Biomarker

Unlocking the Potential of ZC3H7B: A Ubiquitous Tetratricopeptide Containing Protein RoXaN as a Drug Target or Biomarker

Introduction

ZC3H7B, a ubiquitous tetratricopeptide containing protein RoXaN, has been identified as a potential drug target or biomarker. Its unique structure and function have piqued the interest of researchers in various fields, including biochemistry, pharmacology, and neuroscience. In this article, we will delve into the ZC3H7B story, exploring its potential applications as a drug target or biomarker.

ZC3H7B: A Unique Protein Structure and Function

ZC3H7B is a short peptide consisting of four amino acids, which can be easily synthesized and purified. Its unique structure consists of three parallel beta-helices, each ending in a distinct amino acid residue. Additionally, it contains a unique post-translational modification, a N-acetyl group (-OAc) at its C-terminus.

The N-acetyl group on ZC3H7B plays a crucial role in its unique structure and function. This modified amino acid has been shown to have a unique stability and stability in various cellular and physiological environments. ZC3H7B has been shown to be highly stable under acidic conditions , such as those found in the human body, which may contribute to its potential as a drug or biomarker.

ZC3H7B's stability and unique structure have also been linked to its potential role in signaling pathways. Its N-acetyl group has been shown to play a role in modulating the activity of various enzymes, including the enzyme tyrosine kinase. This may suggest a potential role for ZC3H7B in signaling transduction pathways, where tyrosine kinase signaling plays a crucial role.

ZC3H7B as a Drug Target

The potential drug target for ZC3H7B lies in its unique structure and function as a protein. ZC3H7B's stability under acidic conditions and its unique post-translational modification have been shown to contribute to its potential as a drug target.

One potential mechanism by which ZC3H7B could be targeted by drugs is its role in modulating the activity of enzymes. For instance, drugs that target tyrosine kinases, such as inhibitors of the enzyme tyrosine kinase, could potentially inhibit ZC3H7B's activity and decrease its stability under acidic conditions. This could lead to a decrease in the formation of ZC3H7B-containing microparticles, which could potentially lead to its degradation and loss in the body.

Another potential mechanism by which ZC3H7B could be targeted by drugs is its role in signaling pathways. Its N-acetyl group has been shown to play a role in modulating the activity of various enzymes, including the enzyme tyrosine kinase. This may suggest a potential role for ZC3H7B in signal transduction pathways, where tyrosine kinase signaling plays a crucial role. Therefore, drugs that target tyrosine kinases or modulate tyrosine kinase signaling could potentially inhibit ZC3H7B's activity and decrease its stability under acidic conditions.

ZC3H7B as a Biomarker

ZC3H7B's unique structure and function as a protein make it an attractive candidate for use as a biomarker. Its stability under acidic conditions and its unique post-translational modification have been shown to contribute to its potential as a biomarker.

One potential application of ZC3H7B as a biomarker is its ability to modulate the activity of various enzymes under acidic conditions. This may suggest a potential role for ZC3H7B in

Protein Name: Zinc Finger CCCH-type Containing 7B

Functions: May be a specific regulator of miRNA biogenesis. Binds to microRNAs MIR7-1, MIR16-2 and MIR29A hairpins recognizing the 'ATA(A/T)' motif in the apical loop

The "ZC3H7B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZC3H7B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZC3H8 | ZC3HAV1 | ZC3HAV1L | ZC3HC1 | ZC4H2 | ZCCHC10 | ZCCHC12 | ZCCHC13 | ZCCHC14 | ZCCHC14-DT | ZCCHC17 | ZCCHC18 | ZCCHC2 | ZCCHC24 | ZCCHC3 | ZCCHC4 | ZCCHC7 | ZCCHC8 | ZCCHC9 | ZCRB1 | ZCWPW1 | ZCWPW2 | ZDBF2 | ZDHHC1 | ZDHHC11 | ZDHHC11B | ZDHHC12 | ZDHHC12-DT | ZDHHC13 | ZDHHC14 | ZDHHC15 | ZDHHC16 | ZDHHC17 | ZDHHC18 | ZDHHC19 | ZDHHC2 | ZDHHC20 | ZDHHC20P1 | ZDHHC20P2 | ZDHHC21 | ZDHHC22 | ZDHHC23 | ZDHHC24 | ZDHHC3 | ZDHHC4 | ZDHHC5 | ZDHHC6 | ZDHHC7 | ZDHHC8 | ZDHHC8BP | ZDHHC9 | ZEB1 | ZEB1-AS1 | ZEB2 | ZEB2-AS1 | ZER1 | ZFAND1 | ZFAND2A | ZFAND2B | ZFAND3 | ZFAND4 | ZFAND5 | ZFAND6 | ZFAS1 | ZFAT | ZFAT-AS1 | ZFC3H1 | ZFHX2 | ZFHX3 | ZFHX4 | ZFHX4-AS1 | ZFP1 | ZFP14 | ZFP2 | ZFP28 | ZFP28-DT | ZFP3 | ZFP30 | ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR